Use of antifibrotic drugs in familial interstitial pneumonia: analysis of one family

Use of antifibrotic drugs in familial interstitial pneumonia: analysis of one family

Bibliographic Details
Main Authors:	Deborah dos Reis Estrella, Eliane Viana Mancuzo, Ricardo de Amorim Corrêa
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Pneumologia e Tisiologia 2021-12-01
Series:	Jornal Brasileiro de Pneumologia
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132021000601000&tlng=pt

Similar Items

Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia
by: Keishi Sugino, et al.
Published: (2021-03-01)

HGF Expressing Stem Cells in Usual Interstitial Pneumonia Originate from the Bone Marrow and Are Antifibrotic.
by: Amiq Gazdhar, et al.
Published: (2013-01-01)

Use of a pulmosphere model to evaluate drug antifibrotic responses in interstitial lung diseases
by: Kevin G. Dsouza, et al.
Published: (2023-03-01)

Antifibrotic therapies in rheumatoid arthritis associated interstitial lung disease
by: Cemal Bes, et al.
Published: (2022-07-01)

Antifibrotic in interstitial lung diseases: When, where, and how long?
by: Deependra K Rai, et al.
Published: (2022-01-01)

Interstitial lung diseases: the role of HRCT in in the era of antifibrotic therapy
by: Alfredo Nicodemos Cruz Santana, et al.
Published: (2020-11-01)

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
by: Sebastiano Emanuele Torrisi, et al.
Published: (2019-11-01)

The role of antifibrotics in the treatment of rheumatoid arthritis–associated interstitial lung disease
by: Minrui Liang, et al.
Published: (2022-02-01)

Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease
by: Erin M. Wilfong, et al.
Published: (2021-12-01)

Use of Next-Generation Sequencing to Support the Diagnosis of Familial Interstitial Pneumonia
by: Ana Rita Gigante, et al.
Published: (2023-01-01)

Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience
by: Kodai Kawamura, et al.
Published: (2019-06-01)

The Association between MUC5B Rs35705950 and Risks of Idiopathic Interstitial Pneumonia, Systemic Sclerosis Interstitial Lung Disease, and Familial Interstitial Pneumonia: A Meta-Analysis
by: Huai-qing LUO, et al.
Published: (2020-11-01)

Heart rate recovery in 1 minute after the 6-minute walk test predicts adverse outcomes in pulmonary arterial hypertension.
by: Camila Farnese Rezende, et al.
Published: (2022-01-01)

Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD
by: John N. Shumar, et al.
Published: (2021-05-01)

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease
by: Atsushi Kumanogoh, et al.
Published: (2023-01-01)

Antifibrotic Agents in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis
by: Ji Hoon Jang, et al.
Published: (2023-12-01)

Antifibrotic drugs as therapeutic tools in resistant melanoma
by: Berta Sanchez‐Laorden, et al.
Published: (2022-03-01)

Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
by: Gian Luca Erre, et al.
Published: (2021-01-01)

Differences in the Evolution of Lung Function Before and After Treatment With Antifibrotics in Patients With Interstitial Lung Disease
by: Katiuska Herminia Liendo-Martínez, et al.
Published: (2023-10-01)

In Vitro and In Vivo Antifibrotic Effects of Fraxetin on Renal Interstitial Fibrosis via the ERK Signaling Pathway
by: Yi-Hsien Hsieh, et al.
Published: (2021-07-01)

Antifibrotics in India
by: Raja Dhar
Published: (2019-01-01)

Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects
by: Hideki Nawa, et al.
Published: (2022-12-01)

Reactivation of tuberculosis in patient treated with the antifibrotic drug nintedanib
by: Iliya Iliev Krachunov, et al.
Published: (2022-01-01)

HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis
by: Xing Lyu, et al.
Published: (2019-07-01)

The elusive antifibrotic macrophage
by: Adhyatmika eAdhyatmika, et al.
Published: (2015-11-01)

Increasing patient access to spirometry in the Unified Health System in Brazil: no longer a dream but a near reality
by: Ricardo Amorim Corrêa, et al.
Published: (2024-01-01)

A multicenter survey study of antifibrotic use for symptomatic patients with post-COVID-19 interstitial lung abnormalities
by: Sahajal Dhooria, et al.
Published: (2022-01-01)

Erratum: Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group
Published: (2022-01-01)

Three-dimensional spatial analysis of missense variants in RTEL1 identifies pathogenic variants in patients with Familial Interstitial Pneumonia
by: R. Michael Sivley, et al.
Published: (2018-01-01)

Family-based case-control study of exposure to household humidifier disinfectants and risk of idiopathic interstitial pneumonia.
by: Dirga Kumar Lamichhane, et al.
Published: (2019-01-01)

Acurácia do Ecocardiograma Transtorácico como Método de Triagem na Prática Clínica da Investigação da Hipertensão Pulmonar
by: Camila Farnese Rezende, et al.
Published: (2023-08-01)

Six-minute walk test and respiratory muscle strength in patients with uncontrolled severe asthma: a pilot study
by: Luiz Fernando Ferreira Pereira, et al.
Published: (2015-06-01)

PET/CT and inflammatory mediators in systemic sclerosis-associated interstitial lung disease
by: Andréa L Bastos, et al.
Published: (2022-06-01)

Impact of Antifibrotic Treatment on Postoperative Complications in Patients with Interstitial Lung Diseases Undergoing Lung Transplantation: A Systematic Review and Meta-Analysis
by: Pahnwat Taweesedt, et al.
Published: (2023-01-01)

Expression of HSP47 in Usual Interstitial Pneumonia and Nonspecific Interstitial Pneumonia
by: Mine Mariko, et al.
Published: (2005-06-01)

Investigation of mesalazine as an antifibrotic drug following myocardial infarction in male mice
by: Stephan R. Künzel, et al.
Published: (2023-09-01)

The effect of antifibrotic drugs in rat precision-cut fibrotic liver slices.
by: Inge M Westra, et al.
Published: (2014-01-01)

Deciphering the Antifibrotic Property of Metformin
by: Axelle Septembre-Malaterre, et al.
Published: (2022-12-01)

Interstitial Pneumonia in Psoriasis
by: Hironori Kawamoto, MD, et al.
Published: (2018-12-01)

Idiopathic interstitial pneumonias
by: Mikhail M. Ilkovich, et al.
Published: (2021-03-01)